Leaflet ILOPROST ZENTIVA 10mcg / ml solution for inhalation by nebuliser

Product code:
W67924007
Quantity:
30
Indicated for:
pulmonary arterial hypertension
Route of administration:
inhalation
Substance:
iloprost (antihypertensive)
ATC
B01AC11 — Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin
Iloprost is a synthetic analog of prostacyclin used for the treatment of pulmonary arterial hypertension and severe Raynaud's phenomenon. It works by dilating blood vessels and inhibiting platelet aggregation, improving blood flow.

The medication is administered via inhalation or intravenous infusion, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.

Side effects may include headache, dizziness, nausea, or facial flushing. In rare cases, severe hypotension or bleeding may occur.

Iloprost is not recommended for patients with hypersensitivity to this medication or conditions that increase the risk of bleeding.

General data about ILOPROST ZENTIVA 10mcg / ml

Substance:
iloprost
Date of latest medicines list:
01-03-2024
Product code:
W67924007
Concentration:
10mcg / ml
Pharmaceutical form:
solution for inhalation by nebuliser
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ZENTIVA, K.S - REPUBLICA CEHA
Holder:
ZENTIVA K.S. - REPUBLICA CEHA
Number:
14040/2021/07
Shelf life:
3 years

Concentrations available for iloprost

  • 10mcg/ml
  • 20mcg/ml